Bicalutamide
|
-- CAS RN: 90357-06-5
|
-- Chemical Name:N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxyl-2- methylpropanemide
|
-- Structural Formula:
|
-- Molecular formula & molecular weight:C18H14F4N2O4S 430.38
|
-- Characters:A white or almost white crystal powder, odorless, tasteless, freely soluble in DMF; Soluble in butylene oxide; sparingly soluble in acetic ether and methanol; insoluble in water.
|
-- Quality Standard: In-house C18H14F4N2O4S ≥99%
|
-- Usage:Prostate drug, It is developed by AstraZenca Internatioal,and it is the first antiandrogen non-corticosteroids drug for long-acting oral medication and firstly go on the market in 1995 in UK. An antiandrogen non-corticosteroids can be used treating prostate cancer in advanced stage as assistant drug, may also for treating prostate cancer in the early stage to play an important role.
|
-- Storage:It should be kept in room temperature, and away from light; stored in sealed containers.
|
-- Packing:paper bucket, 10kg & 25kg /package
|